Neutrophil elastase inhibitors: a patent review and potential applications for inflammatory lung diseases (2010 – 2014)
- 29 June 2015
- journal article
- review article
- Published by Taylor & Francis in Expert Opinion on Therapeutic Patents
- Vol. 25 (10) , 1145-1158
Abstract
(2015). Neutrophil elastase inhibitors: a patent review and potential applications for inflammatory lung diseases (2010 – 2014) Expert Opinion on Therapeutic Patents: Vol. 25, No. 10, pp. 1145-1158.Keywords
This publication has 78 references indexed in Scilit:
- Molecular mechanisms regulating NETosis in infection and diseaseSeminars in Immunopathology, 2013
- Modulation of neutrophil NETosis: interplay between infectious agents and underlying host physiologySeminars in Immunopathology, 2013
- NETosis and NADPH oxidase: at the intersection of host defense, inflammation, and injuryFrontiers in Immunology, 2013
- NSP4, an elastase-related protease in human neutrophils with arginine specificityProceedings of the National Academy of Sciences, 2012
- Neutrophil Elastase, Proteinase 3, and Cathepsin G as Therapeutic Targets in Human DiseasesPharmacological Reviews, 2010
- Neutrophil elastase and myeloperoxidase regulate the formation of neutrophil extracellular trapsJournal of Cell Biology, 2010
- Leukocyte Elastase Induces Lung Epithelial Apoptosis via a PAR-1–, NF-κB–, and p53-Dependent PathwayAmerican Journal of Respiratory Cell and Molecular Biology, 2009
- Neutrophil elastase in cyclic and severe congenital neutropeniaBlood, 2006
- Neutrophil Extracellular Traps Kill BacteriaScience, 2004
- Augmentation Therapy for ??1-Antitrypsin DeficiencyDrugs, 2004